Barth Syndrome – Patient Worthy

Rare Community Profiles: For Rare Disease Week, Barth Syndrome Advocates Took to Capitol Hill to Urge the FDA to Review NDA for Elamipretide

Post author:Jessica Lynn
Post published:March 26, 2024
Post category:Barth Syndrome

Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

source: shutterstock.com

FDA’s Refusal to Review Rare Disease Treatment Denies Patients’ Right to Try

Post author:Patient Worthy Contributor
Post published:March 19, 2024
Post category:Barth Syndrome

This opinion piece was provided by Kevin Woodward of Phoenix, Maryland. Kevin is a member of the Barth Syndrome Foundation board of directors. The role of the U.S. Food and…

source: shutterstock.com

World Orphan Drug Congress USA 2023: The Challenge of Ultra-Rare Disease Drug Development

Post author:James Moore
Post published:June 15, 2023
Post category:Barth Syndrome Timely

The World Orphan Drug Congress USA 2023 was held from May 23-25, 2023 at the Gaylord National Resort & Convention Center in National Harbor, MD. This conference is focused solely…

Capri23auto / Pixabay

EMA Grants Orphan Drug Designation to Elamipretide for Barth Syndrome

Post author:Kendall Mason
Post published:June 29, 2022
Post category:Barth Syndrome

According to a recent news release from PR Newswire, the European Medicines Agency (EMA) has recently awarded elamipretide its Orphan Drug designation for the treatment of Barth syndrome. This treatment,…

Barth Syndrome Chairman Appeals to the FDA For Appropriate Guidelines When Approving Drugs for Ultra-Rare Diseases

Post author:Rose Duesterwald
Post published:September 24, 2021
Post category:Barth Syndrome

According to an article submitted to StatNews by members of the Barth Syndrome Foundation, the FDA approved the drug Aduhelm in accordance with its accelerated approval program. Although the treatment…

source: pixabay.com

New Fellowship Will Advance Barth Syndrome Research

Post author:Kendall Mason
Post published:June 4, 2021
Post category:Barth Syndrome

Rare disease research is often lacking due to a lack of funding, interest, or awareness. To combat this, the Barth Syndrome Foundation (BSF) and American Heart Association (AHA) have joined…

Alexander’s Story: Diagnosed with Barth Syndrome After Losing Brother

Post author:Kendall Mason
Post published:May 4, 2021
Post category:Barth Syndrome

One-year-old Alexander was diagnosed with Barth syndrome before he was born; his parents knew to test for the condition after their son Elias passed away from complications in 2018. While…

University of Florida Study: Barth Syndrome Gene Therapy Preclinical Results Look Good

Post author:Jean Martell
Post published:December 18, 2018
Post category:Barth Syndrome

A University of Florida research team has announced its results of a gene replacement therapy in the treatment of Barth syndrome, which delivered promising results in its initial phase of testing.…

Rare Community Profiles: For Rare Disease Week, Barth Syndrome Advocates Took to Capitol Hill to Urge the FDA to Review NDA for Elamipretide

FDA’s Refusal to Review Rare Disease Treatment Denies Patients’ Right to Try

World Orphan Drug Congress USA 2023: The Challenge of Ultra-Rare Disease Drug Development

EMA Grants Orphan Drug Designation to Elamipretide for Barth Syndrome

Barth Syndrome Chairman Appeals to the FDA For Appropriate Guidelines When Approving Drugs for Ultra-Rare Diseases

New Fellowship Will Advance Barth Syndrome Research

Alexander’s Story: Diagnosed with Barth Syndrome After Losing Brother

University of Florida Study: Barth Syndrome Gene Therapy Preclinical Results Look Good

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Let’s Work Together!

Keep Up to Date

Learn More